Biostatistics and Programming - More than Just Clinical Trials
Learn how ProPharma’s Biostatisticians and Programmers enabled a small biotech company to derive more meaningful and actionable insights from their legacy data.
Enabling data-driven decision-making through precision analytics.
At ProPharma, our biostatistics and programming team supports our clients through the entire product development journey and excels in transforming complex data into clear, actionable insights. Our global team ensures around-the-clock support and employs the latest industry standards, actively contributing to organizations like CDISC. We offer a comprehensive suite of services, from clinical study design and regulatory strategy support to clinical study execution, and provide real-time insights into what is happening with your data.
Utilizing advanced tools and languages like SAS, R, and Python, our team ensures high-quality, validated results. Our proven track record includes the successful completion of 10 NDA/BLA submissions in the past three years, demonstrating our commitment to excellence and regulatory compliance across a broad spectrum of therapeutic areas.
We can support statistical analysis and programming for a variety of therapeutic areas, including:
We know that statistics and programming aren’t easily understood, and our team is here to help you know what’s going on with your data, in a way that makes sense and can be...
Read MoreWe know that statistics and programming aren’t easily understood, and our team is here to help you know what’s going on with your data, in a way that makes sense and can be explained to those outside the biostatistics and programming realm.
Read LessWe ensure our clients benefit from the most current and compliant practices in the field. Our team members volunteer at CDISC to develop and refine industry standards.
We ensure our clients benefit from the most current and compliant practices in the field. Our team members volunteer at CDISC to develop and refine industry standards.
Read LessOur teams have vast experience communicating with regulatory agencies worldwide, including FDA, EMA, MHRA, PMDA, Health Canada, TGA, NMPA, and more.
Our teams have vast experience communicating with regulatory agencies worldwide, including FDA, EMA, MHRA, PMDA, Health Canada, TGA, NMPA, and more.
Read LessWe have completed 10 NDA/BLA submissions in the last 3 years.
We have completed 10 NDA/BLA submissions in the last 3 years.
Read LessOur team members are located in five countries across the globe, allowing us to work with our sponsors around the clock.
Our team members are located in five countries across the globe, allowing us to work with our sponsors around the clock.
Read LessOur flexible approach allows us to support our clients in whatever model best suits their needs, whether that is full-service CRO, functional service provider (FSP), or ad-hoc...
Read MoreOur flexible approach allows us to support our clients in whatever model best suits their needs, whether that is full-service CRO, functional service provider (FSP), or ad-hoc consulting.
Read LessAt ProPharma, we redefine the landscape of biostatistics and programming by offering far more than mere statistical analysis. Our diverse team of experts delivers unparalleled support across the entire spectrum of the life sciences journey, ensuring that our clients benefit from a holistic and integrated approach. With best-in-class communication skills, we demystify complex statistical processes, ensuring they are accessible and transparent to all stakeholders. This approach facilitates informed decision-making at every level of engagement and fosters a collaborative environment where insights lead to innovation.
Our global, highly experienced team operates across time zones, providing around-the-clock support to our sponsors. When combined with our robust processes and global infrastructure, we accelerate project timelines and enhance quality and consistency across deliverables, significantly mitigating risks and optimizing operational efficiencies. We are flexible to support our clients with an outsourcing model that best suits their needs, including full-service CRO, FSP, or ad-hoc consulting.
Quality and safety are at the heart of everything we do, especially when working with sensitive clinical trial data. Our team completes all work using our GXP-validated SAS server, and data is moved into and out of our environment through SFTPs.
We have programmers who are fluent in SAS, R, and Python languages, enabling us to work on any data type and conduct any data analysis needed. Our experienced team uses ProPharma's proprietary data visualization tool that enables our sponsors to view their data in real-time and to create their own graphics and dashboards providing them with key insights into their clinical trials in real-time.
We ensure that your statistical analysis is valid, complete, supported by the data, and presented in a way that is easy to understand. If you need support for your study data, ProPharma's experienced biostatistics and programming team can help.
Learn how ProPharma’s Biostatisticians and Programmers enabled a small biotech company to derive more meaningful and actionable insights from their legacy data.
June 15, 2026
Discover five key metrics to evaluate CRO success, ensuring timely clinical trials and data integrity while minimizing costs. Learn how to measure them effectively.
June 10, 2026
Learn how bemotrizinol achieved GRASE status and what FDA's final order adding the ingredient to the OTC sunscreen monograph means for manufacturers and product development.
June 18, 2026
ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.
May 27, 2026
ProPharma announces Adrian Pencak as Chief Commercial Officer, bringing 25 years of leadership experience to enhance global commercial capabilities and client partnerships.
January 31, 2025
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.
October 9, 2024
ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.
June 17, 2026
Conducting clinical research for rare pediatric populations presents unique operational challenges, particularly when eligible patients may be born anywhere in the world and require immediate...
June 10, 2026
As advanced therapy developers move from research-stage operations toward commercialization, they often face significant challenges in scaling quality systems, aligning regulatory strategy, and...
June 2, 2026
A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...
April 23, 2026
As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...
April 9, 2026
As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...
June 17, 2026
Conducting clinical research for rare pediatric populations presents unique operational challenges, particularly when eligible patients may be born anywhere in the world and require immediate...
April 9, 2026
As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...